9502 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2023-04-20 |
| Register Year | 2017 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | MEPOLIZUMAB |
| Trade Name | NUCALA 100 mg POWDER FOR SOLUTION FOR INJECTION |
| Strength Unit | mg |
| Pharmaceutical Form | powder for solution for injection |
| Administration Route | Subcutaneous use |
| Atc Code1 | L04AC06 |
| Atc Code2 | |
| Size | 10 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $4113.1 |
| Shelf Life | 48 Months |
| Marketing Company | Glaxo Saudi Arabia Ltd |
| Marketing Country | Saudi Arabia |
| Manufacture Name | GLAXO SMITHKLINE MANUFACTURING S.P.A. |
| Manufacture Country | Italy |
| Secondry package manufacture | |
| Main Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
| Secosnd Agent | |
| Third Agent | |
| Visits | 9502 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| NUCALA 100 mg POWDER FOR SOLUTION FOR IN | $4113.1 | 9502 visits | 2023-04-20 |